Rapidly in situ forming polyphosphoester-based hydrogels for injectable drug delivery carriersElectronic supplementary information (ESI) available: Detailed information on the experimental details, Scheme S1-S2, Table S1, and Fig. S1-S5. See DOI: 10.1039/c2sm25274k

In situ forming hydrogels allow the modulation of physicochemical properties and are providing new opportunities for biomedical applications. Here, the preparation and characterization of a series of rapidly in situ forming and pH-responsive hydrogels with different crosslinking degrees are reported...

Full description

Saved in:
Bibliographic Details
Main Authors He, Jinlin, Zhang, Mingzu, Ni, Peihong
Format Journal Article
LanguageEnglish
Published 16.05.2012
Online AccessGet full text

Cover

Loading…
More Information
Summary:In situ forming hydrogels allow the modulation of physicochemical properties and are providing new opportunities for biomedical applications. Here, the preparation and characterization of a series of rapidly in situ forming and pH-responsive hydrogels with different crosslinking degrees are reported, which were achieved by accelerated free radical copolymerization of polyphosphoester-based macrocrosslinker and 2-(dimethylamino)ethyl methacrylate (DMAEMA) monomer. The hydrogel formation can be completed very quickly under mild conditions, ranging from several to tens of minutes with varying concentrations of components. The polyphosphoester-based macrocrosslinker was synthesized via a combination of ring-opening polymerization and post-polymerization modification, and it was characterized by 1 H NMR, 31 P NMR, and GPC measurements. The sol-gel transition was monitored by dynamic time sweep rheological analysis. Moreover, the swelling kinetics, interior morphology, pH-responsive property, in vitro cytotoxicity and drug release of these hydrogels were characterized. The results indicate that these hydrogels show great potential as injectable drug delivery system. Fabrication of novel rapidly in situ forming polyphosphoester-based hydrogels with adjustable gelation time for injectable drug delivery carriers.
Bibliography:Electronic supplementary information (ESI) available: Detailed information on the experimental details, Scheme S1-S2, Table S1, and Fig. S1-S5. See DOI
10.1039/c2sm25274k
ISSN:1744-683X
1744-6848
DOI:10.1039/c2sm25274k